VANI
Vivani Medical, Inc.
1.25
1 x 0.91
2 x 1.58
bid
ask
+
0.02
1.63%
10:15 AM
timesize
| Ytd | 1.63% | |
| 1y | -1.57% |
1.23
day range
1.28
0.92
52 week range
1.92
| Open | 1.24 | Prev Close | 1.23 | Low | 1.23 | High | 1.28 | Mkt Cap | 107.79M |
| Vol | 482.96K | Avg Vol | 223.65K | EPS | -0.40 | P/E | N/A | Forward P/E | -2.11 |
| Beta | 3.52 | Short Ratio | 12.59 | Inst. Own | 10.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.23 | 200-d Avg | 1.31 | 1yr Est | 5.50 |
| Income Statement | |||
| Operating Expenses | 6.82M | ||
| Research and Development Expense | 4.39M | ||
| Selling, General and Administrative Expense | 2.43M | ||
| Operating Income | -6.82M | ||
| Net Income | -6.78M | ||
| Net Income Common Stock | -6.78M | ||
| Net Income Common Stock (USD) | -6.78M | ||
| Consolidated Income | -6.78M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -6.78M | ||
| Earning Before Interest & Taxes (USD) | -6.78M | ||
| Weighted Average Shares | 81.27M | ||
| Weighted Average Shares Diluted | 81.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.09M | ||
| Cash and Equivalents (USD) | 21.09M | ||
| Trade and Non-Trade Receivables | 12.00K | ||
| Current Assets | 21.55M | ||
| Property, Plant & Equipment Net | 19.37M | ||
| Total Assets | 42.35M | ||
| Total Debt | 16.49M | ||
| Current Liabilities | 6.78M | ||
| Debt Non-Current | 16.49M | ||
| Total Liabilities | 23.27M | ||
| Accumulated Retained Earnings (Deficit) | -155.31M | ||
| Accumulated Other Comprehensive Income | 32.00K | ||
| Shareholders Equity | 19.09M | ||
| Shareholders Equity (USD) | 19.09M | ||
| Assets Non-Current | 20.81M | ||
| Total Debt (USD) | 16.49M | ||
| Liabilities Non-Current | 16.49M | ||
| Trade and Non-Trade Payables | 1.47M | ||
| Tax Assets | 685.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 164.00K | ||
| Net Cash Flow from Financing | 9.71M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.52M | ||
| Capital Expenditure | -3.00K | ||
| Issuance (Purchase) of Equity Shares | 9.82M | ||
| Issuance (Repayment) of Debt Securities | -107.00K | ||
| Net Cash Flow from Investing | -3.00K | ||
| Net Cash Flow from Operations | -6.20M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 312.00K | ||